04:21 PM EDT, 10/22/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on October 18, 2024, sold 42,000 shares in Vaxcyte ( PCVX ) for $4,846,508. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 90,383 shares of the company, with 90,383 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/xslF345X05/wk-form4_1729627909.xml